North America Viral Vector Manufacturing Market: Market Growth and Future Growth (2034)
North America leads the viral vector manufacturing market—holding nearly half of global share—driven by strong biotech infrastructure, rising gene and cell therapy demand, robust R&D funding, and government support. Growth fueled by increasing clinical trials, cancer/genetic disease prevalence, and CDMO expansion